60 /100
HIGH RISK
Score updated May 30, 2026

EZRA — Reliance Global Group, Inc. Dilution Risk Tracker

Track EZRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EZRA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
43%
📜 Warrant Exercise 60%
• Massive warrant overhang: 372% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 38%
• Active shelf registration ($60M, 2747% of market cap)
• Active ATM program with $2M remaining capacity
📉 Score Deterioration 10%
• Score in HIGH risk zone (60/100)
🔔 Track EZRA — Get forecast alerts →

💹 Market Data

Market Cap$2.18M
Shares Outstanding555.8K
Float516.1K
Cash$2.27M
Debt$5.45M
Short InterestN/A

🏛 Institutional Holdings

5.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track EZRA for full holder detail →

📉 Short Interest

Short Interest1.17M
Days to Cover1.0
% of Float226.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jan 29, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2023
8-K 8K EVENT May 04, 2026
424B3 ATM Apr 29, 2026
EFFECT EFFECT Apr 28, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track EZRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EZRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for EZRA
📊 EZRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EZRA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.